CASCINATION AG is an award-winning medical technology company from Bern (Switzerland) dedicated to the development, manufacturing and commercialization of innovations in computer-assisted and image-guided surgery. Our navigation systems and surgical robots are designed to improve outcomes for patients undergoing surgical or interventional procedures and offer new perspectives to patients worldwide.
Quality Ablation with CAS-One IR is used for minimally invasive and highly precise tumour treatments. HEARO is the world's first robotic surgical system for high precision, minimally invasive cochlear implantation. We are continually expanding our technologies and product portfolio into new areas of treatment where precision and reliability can help clinicians to significantly improve treatment outcomes for patients.
| 2024 | 10,000 cumulative patients treated with CAS-One IR |
| 2023 | Artificial Intelligence available in CAS-One IR |
| 2020 | CE Mark for HEARO |
| 2019 | Winner Swiss Medtech Award with HEARO |
| 2017 | European Expansion |
| 2015 | FDA Clearance CAS-One IR |
| 2013 | Winner CTI Swiss Medtech Award with CAS-One IR |
| 2010 | CE Mark for CAS-One IR |
| 2009 | Company founded as spin-off from ARTORG Center, University of Bern |
Awards
| 2019 | Winner Swiss Medtech Award |
| 2017 | Handelszeitung Wachstums-Champion (11th Rank) |
| 2015 | Finalist Swiss Economic Award |
| 2014 | Venture Kick Best Video Award |
| 2013 | Ypsomed InnovationspreisD |
| 2013 | Winner CTI Swiss Medtech Award |
| 2011 | Jungunternehmerpreis |
| 2011 | W.A. de Vigier Entrepreneurship Prize |
| 2011 | Finalist Swiss Technology Award |
| 2010 | CTI Start-up Label |